Valuation: PolyNovo Limited

Market Cap 677M 473M 413M 381M 351M 662M 45.53B 4.56B 1.79B 22.3B 1.78B 1.74B 76.76B P/E 2026 *
90.5x
P/E 2027 * 34.7x
Enterprise Value 651M 455M 398M 367M 338M 637M 43.81B 4.38B 1.72B 21.46B 1.71B 1.67B 73.86B EV / Sales 2026 *
4.3x
EV / Sales 2027 * 3.5x
Free-Float
88.97%
Yield 2026 *
-
Yield 2027 * -
1 day-4.85%
1 week-3.45%
Current month+6.52%
1 month-3.92%
3 months-2.97%
6 months-18.67%
Current year-20.33%
1 week 0.97
Extreme 0.97
1.04
1 month 0.9
Extreme 0.905
1.04
Current year 0.86
Extreme 0.865
1.3
1 year 0.86
Extreme 0.865
1.66
3 years 0.86
Extreme 0.865
2.78
5 years 0.84
Extreme 0.835
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 2025-11-30
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman - 2025-10-26
Director/Board Member 65 2019-10-27
Director/Board Member - 2020-05-12
Date Insider Type Main position Quantity % Market Cap.
3/16/26 Buy

Director

151,000 0.0219%
2/27/26 Buy

Chairman

30,000 0.0043%
2/27/26 Buy

Director

100,000 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-4.85%-3.45%-22.22%-37.38% 473M
+1.87%+7.19%-18.59%-5.86% 175B
-0.43%-0.80%-7.15%-3.93% 106B
-0.03%+1.47%+5.13%+60.04% 59.91B
+0.66%+0.96%+37.64%+54.65% 51.95B
-1.10%+4.10%-11.56%-38.29% 43.58B
-3.21%-3.05% - - 33.65B
-1.71%+2.25%-8.63%-44.43% 29.58B
-1.16%+1.28%+69.87%-6.85% 25.31B
-1.49%+0.85%-3.43%-4.01% 21.23B
Average -1.14%+1.08%+4.56%-2.90% 54.75B
Weighted average by Cap. +0.08%+2.75%-1.62%+3.37%

Financials

2026 *2027 *
Net sales 152M 106M 92.49M 85.34M 78.67M 148M 10.19B 1.02B 401M 4.99B 397M 389M 17.18B 181M 127M 111M 102M 94.18M 178M 12.2B 1.22B 480M 5.98B 476M 465M 20.57B
Net income 7.01M 4.9M 4.28M 3.95M 3.64M 6.86M 472M 47.2M 18.57M 231M 18.39M 17.99M 795M 19.31M 13.48M 11.78M 10.87M 10.02M 18.89M 1.3B 130M 51.12M 636M 50.64M 49.53M 2.19B
Net Debt -25.56M -17.85M -15.6M -14.39M -13.27M -25.01M -1.72B -172M -67.67M -842M -67.03M -65.56M -2.9B -41.66M -29.09M -25.42M -23.46M -21.62M -40.75M -2.8B -280M -110M -1.37B -109M -107M -4.72B
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
26-07-17 A$0.9800 -4.85% 1,069,640
26-07-16 A$1.030 +3.00% 761,725
26-07-15 A$1.000 -2.44% 1,351,611
26-07-14 A$1.025 +0.49% 629,971
26-07-13 A$1.020 +0.49% 1,114,559
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.9800AUD
Average target price
1.705AUD
Spread / Average Target
+73.96%

Quarterly revenue - Rate of surprise